Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (41-50 of 522) with videos related to

Pageof 53
Sort By:
Journal of Diabetes and Its Complications|September 23, 2022
Weight response to GLP-1 receptor agonists: Why women do it better?Mojca Jensterle, Manfredi Rizzo, Andrej Janež
JAMA Internal Medicine|July 24, 2020
Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in ItalyManfredi Rizzo, Luca Foresti, Nicola Montano
Frontiers in Clinical Diabetes and Healthcare|December 24, 2025
Editorial: Non-insulin pharmacotherapies for the treatment of type 2 diabetes and obesity - old and new playersDimitrios Patoulias, Emir Muzurović, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare|March 11, 2025
Cognitive disorders in diabetesKarim Gariani, Dongryeol Ryu, Manfredi Rizzo
European Journal of Internal Medicine|March 5, 2024
Exploring the Landscape of Familial Hypercholesterolemia: Unraveling Genetic Complexity and Clinical ImplicationsFotios Barkas, Evangelos Liberopoulos, Manfredi Rizzo
Current Opinion in Cardiology|March 8, 2024
Clinical impact of genetic testing for lipid disordersEmir Muzurović, Sanja Borozan, Manfredi Rizzo
Current Vascular Pharmacology|January 12, 2013
Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASHManfredi Rizzo, Giuseppe Montalto, Manlio Vinciguerra
Current Opinion in Cardiology|April 28, 2018
New antihyperglycaemic agents and cardiovascular disease: let's be optimisticKalliopi Pafili, Manfredi Rizzo, Nikolaos Papanas
Journal of Diabetes and Its Complications|October 30, 2024
Precision diabetology: Where do we stand now?Christian Herder, Manfredi Rizzo, Michael Roden
Expert Review of Clinical Pharmacology|August 4, 2022
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetesManfredi Rizzo, Francesco Cosentino, Christos Mantzoros
Pageof 53

Showing results (41-50 of 522) with videos related to

Sort By:
Pageof 53
Journal of Diabetes and Its Complications|September 23, 2022
Weight response to GLP-1 receptor agonists: Why women do it better?Mojca Jensterle, Manfredi Rizzo, Andrej Janež
JAMA Internal Medicine|July 24, 2020
Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in ItalyManfredi Rizzo, Luca Foresti, Nicola Montano
Frontiers in Clinical Diabetes and Healthcare|December 24, 2025
Editorial: Non-insulin pharmacotherapies for the treatment of type 2 diabetes and obesity - old and new playersDimitrios Patoulias, Emir Muzurović, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare|March 11, 2025
Cognitive disorders in diabetesKarim Gariani, Dongryeol Ryu, Manfredi Rizzo
European Journal of Internal Medicine|March 5, 2024
Exploring the Landscape of Familial Hypercholesterolemia: Unraveling Genetic Complexity and Clinical ImplicationsFotios Barkas, Evangelos Liberopoulos, Manfredi Rizzo
Current Opinion in Cardiology|March 8, 2024
Clinical impact of genetic testing for lipid disordersEmir Muzurović, Sanja Borozan, Manfredi Rizzo
Current Vascular Pharmacology|January 12, 2013
Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASHManfredi Rizzo, Giuseppe Montalto, Manlio Vinciguerra
Current Opinion in Cardiology|April 28, 2018
New antihyperglycaemic agents and cardiovascular disease: let's be optimisticKalliopi Pafili, Manfredi Rizzo, Nikolaos Papanas
Journal of Diabetes and Its Complications|October 30, 2024
Precision diabetology: Where do we stand now?Christian Herder, Manfredi Rizzo, Michael Roden
Expert Review of Clinical Pharmacology|August 4, 2022
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetesManfredi Rizzo, Francesco Cosentino, Christos Mantzoros
Pageof 53